$NUVB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Nuvation Bio Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Nuvation Bio Inc.. Get notifications about new insider transactions in Nuvation Bio Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13 2021 | NUVB | Nuvation Bio Inc. | NODELMAN OLEG | Director | Buy | P | 10.27 | 3,966 | 40,735 | 1,355,625 | 1.4 M to 1.4 M (+0.29 %) |
| Apr 13 2021 | NUVB | Nuvation Bio Inc. | NODELMAN OLEG | Director | Buy | P | 10.27 | 27,534 | 282,802 | 6,990,265 | 7 M to 7 M (+0.40 %) |
| Apr 13 2021 | NUVB | Nuvation Bio Inc. | NODELMAN OLEG | Director | Buy | P | 9.49 | 16,745 | 158,873 | 1,351,659 | 1.3 M to 1.4 M (+1.25 %) |
| Apr 13 2021 | NUVB | Nuvation Bio Inc. | NODELMAN OLEG | Director | Buy | P | 9.49 | 116,255 | 1,103,004 | 6,962,731 | 6.8 M to 7 M (+1.70 %) |
| Apr 13 2021 | NUVB | Nuvation Bio Inc. | NODELMAN OLEG | Director | Buy | P | 10.03 | 37,770 | 378,856 | 1,334,914 | 1.3 M to 1.3 M (+2.91 %) |
| Apr 13 2021 | NUVB | Nuvation Bio Inc. | NODELMAN OLEG | Director | Buy | P | 10.03 | 262,230 | 2,630,324 | 6,846,476 | 6.6 M to 6.8 M (+3.98 %) |
| Apr 01 2021 | NUVB | Nuvation Bio Inc. | Bazemore Robert B | Director | Buy | P | 9.98 | 5,000 | 49,900 | 5,000 | 0 to 5 K |
| Mar 11 2021 | NUVB | Nuvation Bio Inc. | Hung David | President and CEO | Option Exercise | A | 12.66 | 224,760 | 2,845,462 | 224,760 | |
| Mar 11 2021 | NUVB | Nuvation Bio Inc. | Hung David | President and CEO | Option Exercise | A | 12.66 | 165,465 | 2,094,787 | 165,465 | |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | Sharp Shalini | Director | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | Sharp Shalini | Director | Grant | A | 10.00 | 10,000 | 100,000 | 35,000 | 25 K to 35 K (+40.00 %) |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | Sharp Shalini | Director | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | BRADBURY DANIEL | Director | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | BRADBURY DANIEL | Director | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | Hasnain Faheem | Director | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | Hasnain Faheem | Director | Grant | A | 10.00 | 30,000 | 300,000 | 55,000 | 25 K to 55 K (+120.00 %) |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | Hasnain Faheem | Director | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | COOPER GRAHAM K | Director | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | COOPER GRAHAM K | Director | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Option Exercise | A | 11.50 | 131,333 | 1,510,330 | 131,333 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Option Exercise | A | 11.50 | 702,000 | 8,073,000 | 702,000 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Option Exercise | A | 11.50 | 130,000 | 1,495,000 | 130,000 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Option Exercise | C | 0.00 | 2,775,000 | 0 | 0 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Grant | A | 0.00 | 2,200,627 | 0 | 2,200,627 | 0 to 2.2 M |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Grant | A | 0.00 | 515,879 | 0 | 1,297,144 | 781.3 K to 1.3 M (+66.03 %) |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Grant | A | 0.00 | 2,365,511 | 0 | 6,584,246 | 4.2 M to 6.6 M (+56.07 %) |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Grant | A | 10.00 | 387,265 | 3,872,650 | 781,265 | 394 K to 781.3 K (+98.29 %) |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Grant | A | 10.00 | 2,112,735 | 21,127,350 | 4,218,735 | 2.1 M to 4.2 M (+100.32 %) |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Grant | A | 0.00 | 394,000 | 0 | 394,000 | 0 to 394 K |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Grant | A | 0.00 | 2,106,000 | 0 | 2,106,000 | 0 to 2.1 M |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | NODELMAN OLEG | Director | Buy | C | 0.00 | 2,775,000 | 0 | 3,165,000 | 390 K to 3.2 M (+711.54 %) |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Omega Fund V, L.P. | 10% Owner | Option Exercise | C | 0.00 | 8,130,097 | 0 | 0 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Omega Fund V, L.P. | 10% Owner | Grant | A | 10.00 | 500,000 | 5,000,000 | 28,212,373 | 27.7 M to 28.2 M (+1.80 %) |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Omega Fund V, L.P. | 10% Owner | Buy | C | 0.00 | 8,130,097 | 0 | 27,712,373 | 19.6 M to 27.7 M (+41.52 %) |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | VERNON W ANTHONY | Director | Option Exercise | A | 1.74 | 187,658 | 326,525 | 187,658 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | VERNON W ANTHONY | Director | Option Exercise | A | 4.60 | 51,703 | 237,834 | 51,703 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | VERNON W ANTHONY | Director | Grant | A | 10.00 | 50,000 | 500,000 | 304,100 | 254.1 K to 304.1 K (+19.68 %) |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | VERNON W ANTHONY | Director | Grant | A | 0.00 | 254,100 | 0 | 254,100 | 0 to 254.1 K |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | FALBERG KATHRYN E | Director | Option Exercise | A | 4.60 | 239,361 | 1,101,061 | 239,361 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | BLICKENSTAFF KIM D | Director | Option Exercise | A | 1.74 | 187,658 | 326,525 | 187,658 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | BLICKENSTAFF KIM D | Director | Option Exercise | A | 4.60 | 51,703 | 237,834 | 51,703 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Bazemore Robert B | Director | Option Exercise | A | 1.74 | 187,658 | 326,525 | 187,658 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Bazemore Robert B | Director | Option Exercise | A | 4.60 | 51,703 | 237,834 | 51,703 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | WELCH DANIEL G | Director | Option Exercise | A | 1.74 | 312,750 | 544,185 | 312,750 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | WELCH DANIEL G | Director | Option Exercise | A | 4.60 | 86,184 | 396,446 | 86,184 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Markel Stacy | SVP, Human Resource ... | Option Exercise | A | 1.74 | 254,810 | 443,369 | 254,810 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Markel Stacy | SVP, Human Resource ... | Option Exercise | A | 4.60 | 398,935 | 1,835,101 | 398,935 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Templeman Thomas | SVP, Pharmaceutical ... | Option Exercise | A | 1.74 | 398,935 | 694,147 | 398,935 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Templeman Thomas | SVP, Pharmaceutical ... | Option Exercise | A | 4.60 | 398,935 | 1,835,101 | 398,935 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Hattersley Gary | Chief Scientific Of ... | Option Exercise | A | 1.74 | 398,935 | 694,147 | 398,935 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Hattersley Gary | Chief Scientific Of ... | Option Exercise | A | 4.60 | 398,935 | 1,835,101 | 398,935 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Yurasov Sergey | Chief Medical Offic ... | Option Exercise | A | 1.74 | 398,935 | 694,147 | 398,935 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Yurasov Sergey | Chief Medical Offic ... | Option Exercise | A | 4.60 | 398,935 | 1,835,101 | 398,935 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Fox Jennifer A. | Chief Financial Off ... | Option Exercise | A | 4.60 | 558,506 | 2,569,128 | 558,506 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Fox Jennifer A. | Chief Financial Off ... | Option Exercise | A | 4.60 | 398,935 | 1,835,101 | 398,935 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Hung David | President and CEO | Option Exercise | A | 0.00 | 1,000,000 | 0 | 1,000,000 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Hung David | President and CEO | Grant | A | 10.00 | 2,000,000 | 20,000,000 | 58,645,012 | 56.6 M to 58.6 M (+3.53 %) |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Hung David | President and CEO | Grant | A | 0.00 | 56,645,012 | 0 | 56,645,012 | 0 to 56.6 M |
| Jul 06 2020 | PANA | Panacea Acquisitio ... | EcoR1 Panacea Holdings, LLC | Director | Buy | P | 10.00 | 390,000 | 3,900,000 | 390,000 | 0 to 390 K |
Page: 1